GlassScriptPhysician profile
James W Van Riper
NPI 1467446484
$11,239.04
in general payments reported to CMS, 2019-2025
18 companies · $9,334 in 2025
The $9,334 reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.40 · 2021: $52.86 · 2022: $129 · 2023: $375 · 2024: $1,297 · 2025: $9,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Food and Beverage: $1,132 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Travel and Lodging: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Food and Beverage | $1,131.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Travel and Lodging | $874.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,184.18 | 2023-2025 | Da Vinci Surgical System |
| Astellas Pharma US INC | $280.81 | 2023-2025 | Veozah |
| Abbvie INC. | $184.77 | 2021-2024 | Liletta |
| Organon LLC | $126.89 | 2024-2025 | Jada System, Nexplanon |
| Conmed Corporation | $66.67 | 2023-2024 | Airseal |
| Hologic Sales and Service, LLC | $58.86 | 2025 | Aptima |
| Exeltis, USA INC. | $42.92 | 2023-2024 | Slynd |
| Pfizer INC. | $40.79 | 2022 | |
| Medtronic, INC. | $38.35 | 2022 | |
| Avion Pharmaceuticals | $31.68 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $30.13 | 2021 | |
| Ethicon US, LLC | $29.09 | 2025 | Surgiflo Hemostatic Matrix, Dermabond, Stratafix |
| Octapharma USA, INC. | $27.64 | 2025 | Fibryga |
| Coopersurgical, INC. | $23.76 | 2025 | Paragard T 380a |
| Boston Scientific Corporation | $23.43 | 2025 | Bulkamid |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $23.12 | 2019 | |
| Allergan, INC. | $13.02 | 2019 | |
| Baxter Healthcare | $12.93 | 2023 | Tisseel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Van Riper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.